Organs-on-chips: into the next decade.
Journal
Nature reviews. Drug discovery
ISSN: 1474-1784
Titre abrégé: Nat Rev Drug Discov
Pays: England
ID NLM: 101124171
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
accepted:
08
07
2020
pubmed:
12
9
2020
medline:
16
7
2021
entrez:
11
9
2020
Statut:
ppublish
Résumé
Organs-on-chips (OoCs), also known as microphysiological systems or 'tissue chips' (the terms are synonymous), have attracted substantial interest in recent years owing to their potential to be informative at multiple stages of the drug discovery and development process. These innovative devices could provide insights into normal human organ function and disease pathophysiology, as well as more accurately predict the safety and efficacy of investigational drugs in humans. Therefore, they are likely to become useful additions to traditional preclinical cell culture methods and in vivo animal studies in the near term, and in some cases replacements for them in the longer term. In the past decade, the OoC field has seen dramatic advances in the sophistication of biology and engineering, in the demonstration of physiological relevance and in the range of applications. These advances have also revealed new challenges and opportunities, and expertise from multiple biomedical and engineering fields will be needed to fully realize the promise of OoCs for fundamental and translational applications. This Review provides a snapshot of this fast-evolving technology, discusses current applications and caveats for their implementation, and offers suggestions for directions in the next decade.
Identifiants
pubmed: 32913334
doi: 10.1038/s41573-020-0079-3
pii: 10.1038/s41573-020-0079-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-361Références
Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat. Rev. Drug Discov. 9, 203 (2010).
pubmed: 20168317
doi: 10.1038/nrd3078
pmcid: 20168317
Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191 (2012).
pubmed: 22378269
doi: 10.1038/nrd3681
pmcid: 22378269
Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110, 3507–3512 (2013).
pubmed: 23401516
pmcid: 3587220
doi: 10.1073/pnas.1222878110
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C. & Rosenthal, J. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32, 40 (2014).
pubmed: 24406927
doi: 10.1038/nbt.2786
pmcid: 24406927
Waring, M. J. et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14, 475 (2015).
pubmed: 26091267
doi: 10.1038/nrd4609
pmcid: 26091267
Sweeney, L. M., Shuler, M. L., Babish, J. G. & Ghanem, A. A cell culture analogue of rodent physiology: Application to naphthalene toxicology. Toxicol. In Vitro 9, 307–316 (1995).
pubmed: 20650092
doi: 10.1016/0887-2333(95)00007-U
pmcid: 20650092
Sin, A. et al. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol. Prog. 20, 338–345 (2004).
pubmed: 14763861
doi: 10.1021/bp034077d
pmcid: 14763861
Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010). Early OoC study recreating the alveolar–capillary interface of the human lung incorporating cyclic biomechanical stretch forces and showing replication of in vivo responses.
pubmed: 20576885
pmcid: 8335790
doi: 10.1126/science.1188302
Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687 (2018).
pubmed: 30228295
doi: 10.1038/s41576-018-0051-9
pmcid: 30228295
Ingber, D. E. Reverse engineering human pathophysiology with organs-on-chips. Cell 164, 1105–1109 (2016).
pubmed: 26967278
doi: 10.1016/j.cell.2016.02.049
pmcid: 26967278
Pamies, D. et al. A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity. ALTEX https://doi.org/10.14573/altex.1609122 (2016).
doi: 10.14573/altex.1609122
pubmed: 27883356
pmcid: 6047513
Plummer, S. et al. A human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine. Sci. Rep. 9, 1407 (2019).
pubmed: 30723234
pmcid: 6363784
doi: 10.1038/s41598-018-38130-0
Schwartz, M. P. et al. Human pluripotent stem cell-derived neural constructs for predicting neural toxicity. Proc. Natl Acad. Sci. USA 112, 12516–12521 (2015).
pubmed: 26392547
pmcid: 4603492
doi: 10.1073/pnas.1516645112
Rothbauer, M., Rosser, J. M., Zirath, H. & Ertl, P. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models. Curr. Opin. Biotechnol. 55, 81–86 (2019).
pubmed: 30189349
doi: 10.1016/j.copbio.2018.08.009
pmcid: 30189349
Kasendra, M. et al. Development of a primary human small intestine-on-a-chip using biopsy-derived organoids. Sci. Rep. 8, 2871 (2018).
pubmed: 29440725
pmcid: 5811607
doi: 10.1038/s41598-018-21201-7
Ramme, A. P. et al. Towards an autologous iPSC-derived patient-on-a-chip. bioRxiv https://doi.org/10.1101/376970 (2018).
doi: 10.1101/376970
Vatine, G. D. et al. Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell 24, 995–1005.e1006 (2019).
pubmed: 31173718
doi: 10.1016/j.stem.2019.05.011
pmcid: 31173718
Caliari, S. R. & Burdick, J. A. A practical guide to hydrogels for cell culture. Nat. Methods 13, 405 (2016).
pubmed: 27123816
pmcid: 5800304
doi: 10.1038/nmeth.3839
Crapo, P. M., Tottey, S., Slivka, P. F. & Badylak, S. F. Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering. Tissue Eng. Part. A 20, 313–323 (2013).
pubmed: 24004192
pmcid: 3875189
doi: 10.1089/ten.tea.2013.0186
Safaee, H. et al. Tethered jagged-1 synergizes with culture substrate stiffness to modulate notch-induced myogenic progenitor differentiation. Cell. Mol. Bioeng. 10, 501–513 (2017).
pubmed: 31719873
pmcid: 6816693
doi: 10.1007/s12195-017-0506-7
Trappmann, B. et al. Matrix degradability controls multicellularity of 3D cell migration. Nat. Commun. 8, 371 (2017).
pubmed: 28851858
pmcid: 5575316
doi: 10.1038/s41467-017-00418-6
Shin, D. S. et al. Synthesis of microgel sensors for spatial and temporal monitoring of protease activity. ACS Biomater. Sci. Eng. 4, 378–387 (2018).
pubmed: 29527570
doi: 10.1021/acsbiomaterials.7b00017
pmcid: 29527570
Wikswo, J. P. et al. Engineering challenges for instrumenting and controlling integrated organ-on-chip systems. IEEE Trans. Biomed. Eng. 60, 682–690 (2013).
pubmed: 23380852
pmcid: 3696887
doi: 10.1109/TBME.2013.2244891
Wikswo, J. P. et al. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip 13, 3496–3511 (2013).
pubmed: 23828456
pmcid: 3818688
doi: 10.1039/c3lc50243k
Johnson, B. P. et al. Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase. Proc. Natl Acad. Sci. USA 111, 18757 (2014).
pubmed: 25512522
pmcid: 4284582
doi: 10.1073/pnas.1421708111
Bass, J. & Takahashi, J. S. Circadian integration of metabolism and energetics. Science 330, 1349 (2010).
pubmed: 21127246
pmcid: 3756146
doi: 10.1126/science.1195027
Cyr, K. J., Avaldi, O. M. & Wikswo, J. P. Circadian hormone control in a human-on-a-chip: In vitro biology’s ignored component? Exp. Biol. Med. 242, 1714–1731 (2017).
doi: 10.1177/1535370217732766
Chang, S.-Y. et al. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight https://doi.org/10.1172/jci.insight.95978 (2017). Physically coupled liver and kidney OoCs used to uncover the mechanism of nephrotoxicity of aristolochic acid via bioactivation in the liver, showing utility of coupled OoCs for understanding toxic effects.
doi: 10.1172/jci.insight.95978
pubmed: 29202460
pmcid: 5752380
Phan, D. T. T. et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Lab Chip 17, 511–520 (2017).
pubmed: 28092382
pmcid: 6995340
doi: 10.1039/C6LC01422D
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D. & Yu, H. Towards a human-on-chip: Culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 9, 3185–3192 (2009).
pubmed: 19865724
doi: 10.1039/b915147h
pmcid: 19865724
Materne, E.-M. et al. The multi-organ chip - a microfluidic platform for long-term multi-tissue coculture. J. Vis. Exp. https://doi.org/10.3791/52526 (2015).
doi: 10.3791/52526
pubmed: 25992921
pmcid: 4541596
Maschmeyer, I. et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15, 2688–2699 (2015). Development of a multi-organ integrated OoC with pulsatile flow which reliably supports homeostasis over 28 days and allows ADME profiling and repeated dose drug testing.
pubmed: 25996126
doi: 10.1039/C5LC00392J
pmcid: 25996126
Tsamandouras, N. et al. Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies. AAPS J. 19, 1499–1512 (2017).
pubmed: 28752430
doi: 10.1208/s12248-017-0122-4
pmcid: 28752430
Oleaga, C. et al. Multi-organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci. Rep. 6, 20030 (2016). Development of a multi-organ pumpless OoC with common medium under serum-free conditions, maintaining tissues to 14 days and profiling accurate acute responses to therapeutic compounds.
pubmed: 26837601
pmcid: 4738272
doi: 10.1038/srep20030
Oleaga, C. et al. Human-on-a-chip systems: long-term electrical and mechanical function monitoring of a human-on-a-chip system (Adv. Funct. Mater. 8/2019). Adv. Funct. Mater. 29, 1970049 (2019).
doi: 10.1002/adfm.201970049
Stone, H. A., Stroock, A. D. & Ajdari, A. Engineering flows in small devices: microfluidics toward a lab-on-a-chip. Annu. Rev. Fluid Mech. 36, 381–411 (2004).
doi: 10.1146/annurev.fluid.36.050802.122124
Lochovsky, C., Yasotharan, S. & Günther, A. Bubbles no more: in-plane trapping and removal of bubbles in microfluidic devices. Lab Chip 12, 595–601 (2012).
pubmed: 22159026
doi: 10.1039/C1LC20817A
Kaarj, K. & Yoon, J.-Y. Methods of delivering mechanical stimuli to organ-on-a-chip. Micromachines https://doi.org/10.3390/mi10100700 (2019).
doi: 10.3390/mi10100700
pubmed: 31615136
pmcid: 6843435
Kim, H. J., Huh, D., Hamilton, G. & Ingber, D. E. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12, 2165–2174 (2012).
pubmed: 22434367
doi: 10.1039/c2lc40074j
Maoz, B. M. et al. Organs-on-chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. Lab Chip 17, 2294–2302 (2017).
pubmed: 28608907
doi: 10.1039/C7LC00412E
pmcid: 28608907
Herland, A. et al. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip. PLoS ONE 11, e0150360 (2016).
pubmed: 26930059
pmcid: 4773137
doi: 10.1371/journal.pone.0150360
Musah, S. et al. Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. Nat. Biomed. Eng. 1, 0069 (2017).
pubmed: 29038743
pmcid: 5639718
doi: 10.1038/s41551-017-0069
Agarwal, A., Goss, J. A., Cho, A., McCain, M. L. & Parker, K. K. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 13, 3599–3608 (2013).
pubmed: 23807141
pmcid: 3786400
doi: 10.1039/c3lc50350j
Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes. Nat. Methods 10, 781 (2013).
pubmed: 23793239
pmcid: 4071061
doi: 10.1038/nmeth.2524
Lee-Montiel, F. T. et al. Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. Exp. Biol. Med. 242, 1617–1632 (2017).
doi: 10.1177/1535370217703978
Senutovitch, N. et al. Fluorescent protein biosensors applied to microphysiological systems. Exp. Biol. Med. 240, 795–808 (2015).
doi: 10.1177/1535370215584934
Zhang, Y. S. et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc. Natl Acad. Sci. USA 114, E2293 (2017). Advanced multi-organ platform for automated control and biosensing over multiple days, including pH, O
pubmed: 28265064
pmcid: 5373350
doi: 10.1073/pnas.1612906114
Toepke, M. W. & Beebe, D. J. PDMS absorption of small molecules and consequences in microfluidic applications. Lab Chip 6, 1484–1486 (2006).
pubmed: 17203151
doi: 10.1039/b612140c
pmcid: 17203151
Markov, D. A., Lillie, E. M., Garbett, S. P. & McCawley, L. J. Variation in diffusion of gases through PDMS due to plasma surface treatment and storage conditions. Biomed. Microdevices 16, 91–96 (2014).
pubmed: 24065585
pmcid: 3945670
doi: 10.1007/s10544-013-9808-2
Tan, S. H., Nguyen, N.-T., Chua, Y. C. & Kang, T. G. Oxygen plasma treatment for reducing hydrophobicity of a sealed polydimethylsiloxane microchannel. Biomicrofluidics 4, 032204 (2010).
pmcid: 2967237
doi: 10.1063/1.3466882
Chuah, Y. J. et al. Simple surface engineering of polydimethylsiloxane with polydopamine for stabilized mesenchymal stem cell adhesion and multipotency. Sci. Rep. 5, 18162 (2015).
pubmed: 26647719
pmcid: 4673458
doi: 10.1038/srep18162
van Meer, B. J. et al. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem. Biophys. Res. Commun. 482, 323–328 (2017).
pubmed: 27856254
pmcid: 5240851
doi: 10.1016/j.bbrc.2016.11.062
Regehr, K. J. et al. Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip 9, 2132–2139 (2009).
pubmed: 19606288
pmcid: 2792742
doi: 10.1039/b903043c
Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018–1028 (2006).
pubmed: 16908486
doi: 10.1056/NEJMoa063842
pmcid: 16908486
Kaur, R., Sidhu, P. & Singh, S. What failed BIA 10-2474 phase I clinical trial? Global speculations and recommendations for future phase I trials. J. Pharmacol. Pharmacother. 7, 120–126 (2016).
pubmed: 27651707
pmcid: 5020770
doi: 10.4103/0976-500X.189661
Fowler, S. et al. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization. Lab Chip 20, 446–467 (2020).
pubmed: 31932816
doi: 10.1039/C9LC00857H
pmcid: 31932816
Fabre, K. et al. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications. Lab Chip 20, 1049–1057 (2020).
pubmed: 32073020
doi: 10.1039/C9LC01168D
pmcid: 32073020
Rudmann, D. G. The emergence of microphysiological systems (organs-on-chips) as paradigm-changing tools for toxicologic pathology. Toxicol. Pathol. 47, 4–10 (2018).
pubmed: 30407146
doi: 10.1177/0192623318809065
pmcid: 30407146
Gerets, H. H. J. et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol. Toxicol. 28, 69–87 (2012).
pubmed: 22258563
pmcid: 3303072
doi: 10.1007/s10565-011-9208-4
Heslop, J. A. et al. Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch. Toxicol. 91, 439–452 (2017).
pubmed: 27039104
doi: 10.1007/s00204-016-1694-y
pmcid: 27039104
Vernetti, L. A. et al. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp. Biol. Med. 241, 101–114 (2016).
doi: 10.1177/1535370215592121
Li, X., George, S. M., Vernetti, L., Gough, A. H. & Taylor, D. L. A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. Lab Chip 18, 2614–2631 (2018).
pubmed: 30063238
pmcid: 6113686
doi: 10.1039/C8LC00418H
Jang, K.-J. et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci. Transl. Med. 11, eaax5516 (2019). First article to compare rat, dog and human microfluidic multicellular liver chips after exposure to hepatotoxic compounds. A fibrotic liver model showed species differences highlighting species-specific differences in drug metabolism and toxicity.
pubmed: 31694927
doi: 10.1126/scitranslmed.aax5516
pmcid: 31694927
Mathur, A. et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 5, 8883 (2015).
pubmed: 25748532
pmcid: 4352848
doi: 10.1038/srep08883
Ahn, S. et al. Mussel-inspired 3D fiber scaffolds for heart-on-a-chip toxicity studies of engineered nanomaterials. Anal. Bioanal. Chem. 410, 6141–6154 (2018).
pubmed: 29744562
pmcid: 6230313
doi: 10.1007/s00216-018-1106-7
Marsano, A. et al. Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip 16, 599–610 (2016).
pubmed: 26758922
doi: 10.1039/C5LC01356A
pmcid: 26758922
Lind, J. U. et al. Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat. Mater. 16, 303 (2016).
pubmed: 27775708
pmcid: 5321777
doi: 10.1038/nmat4782
Capulli, A. K., MacQueen, L. A., O’Connor, B. B., Dauth, S. & Parker, K. K. Acute pergolide exposure stiffens engineered valve interstitial cell tissues and reduces contractility in vitro. Cardiovas. Pathol. 25, 316–324 (2016).
doi: 10.1016/j.carpath.2016.04.004
Goversen, B., van der Heyden, M. A. G., van Veen, T. A. B. & de Boer, T. P. The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on IK1. Pharmacol. Ther. 183, 127–136 (2018).
pubmed: 28986101
doi: 10.1016/j.pharmthera.2017.10.001
pmcid: 28986101
Sheehy, S. P. et al. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes. Exp. Biol. Med. 242, 1643–1656 (2017).
doi: 10.1177/1535370217701006
Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239–243 (2018). OoC used to show enhanced maturation of stem cell-derived cardiac tissues in three dimensions when subjected to electrical stimulation protocols, addressing a key challenge in cardiac stem cell differentiation.
pubmed: 29618819
pmcid: 5895513
doi: 10.1038/s41586-018-0016-3
Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913–927.e918 (2019).
pubmed: 30686581
pmcid: 6456036
doi: 10.1016/j.cell.2018.11.042
Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372 (2017).
pubmed: 28916735
pmcid: 5635889
doi: 10.1073/pnas.1707316114
Giacomelli, E. et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell 26, 862–879.e811 (2020).
pubmed: 32459996
pmcid: 7284308
doi: 10.1016/j.stem.2020.05.004
Jang, K.-J. et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. 5, 1119–1129 (2013).
doi: 10.1039/c3ib40049b
Kim, S. et al. Pharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip. Biofabrication 8, 015021 (2016).
pubmed: 27011358
doi: 10.1088/1758-5090/8/1/015021
pmcid: 27011358
Weber, E. J. et al. Development of a microphysiological model of human kidney proximal tubule function. Kidney Int. 90, 627–637 (2016).
pubmed: 27521113
pmcid: 4987715
doi: 10.1016/j.kint.2016.06.011
Weber, E. J. et al. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight https://doi.org/10.1172/jci.insight.123673 (2018).
doi: 10.1172/jci.insight.123673
pubmed: 30568031
pmcid: 6338315
Kim, H. J. & Ingber, D. E. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr. Biol. 5, 1130–1140 (2013).
doi: 10.1039/c3ib40126j
Workman, M. J. et al. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat. Med. 23, 49 (2016).
pubmed: 27869805
pmcid: 5562951
doi: 10.1038/nm.4233
Williamson, I. A. et al. A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology. Cell. Mol. Gastroenterol. Hepatol. 6, 301–319 (2018).
pubmed: 30123820
pmcid: 6092482
doi: 10.1016/j.jcmgh.2018.05.004
Shah, P. et al. A microfluidics-based in vitro model of the gastrointestinal human–microbe interface. Nat. Commun. 7, 11535 (2016).
pubmed: 27168102
pmcid: 4865890
doi: 10.1038/ncomms11535
Workman, M. J. et al. Enhanced utilization of induced pluripotent stem cell–derived human intestinal organoids using microengineered chips. Cell. Mol. Gastroenterol. Hepatol. 5, 669–677.e662 (2018).
pubmed: 29930984
doi: 10.1016/j.jcmgh.2017.12.008
pmcid: 29930984
Tovaglieri, A. et al. Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. Microbiome 7, 43 (2019).
pubmed: 30890187
pmcid: 6425591
doi: 10.1186/s40168-019-0650-5
Jalili-Firoozinezhad, S. et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat. Biomed. Eng. 3, 520–531 (2019).
pubmed: 31086325
pmcid: 6658209
doi: 10.1038/s41551-019-0397-0
Benam, K. H. et al. in 3D Cell Culture: Methods and Protocols (ed. Koledova, Z.) 345–365 (Springer, 2017).
Benam, K. H. et al. Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip. Cell Syst. 3, 456–466.e454 (2016).
pubmed: 27894999
doi: 10.1016/j.cels.2016.10.003
pmcid: 27894999
Blundell, C. et al. Placental drug transport-on-a-chip: a microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier. Adv. Healthc. Mater. 7, 1700786 (2018).
doi: 10.1002/adhm.201700786
Yin, F. et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol. In Vitro 54, 105–113 (2019).
pubmed: 30248392
doi: 10.1016/j.tiv.2018.08.014
pmcid: 30248392
Sobrino, A. et al. 3D microtumors in vitro supported by perfused vascular networks. Sci. Rep. 6, 31589 (2016).
pubmed: 27549930
pmcid: 4994029
doi: 10.1038/srep31589
Barrile, R. et al. Organ-on-chip recapitulates thrombosis induced by an anti-CD154 monoclonal antibody: translational potential of advanced microengineered systems. Clin. Pharmacol. Ther. 104, 1240–1248 (2018).
pubmed: 29484632
doi: 10.1002/cpt.1054
pmcid: 29484632
Cook, D. et al. Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat. Rev. Drug Discov. 13, 419–431 (2014).
pubmed: 24833294
doi: 10.1038/nrd4309
pmcid: 24833294
Horton, R. E. et al. Angiotensin II induced cardiac dysfunction on a chip. PLoS ONE 11, e0146415 (2016).
pubmed: 26808388
pmcid: 4725954
doi: 10.1371/journal.pone.0146415
Hinson, J. T. et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349, 982–986 (2015).
pubmed: 26315439
pmcid: 4618316
doi: 10.1126/science.aaa5458
Nesmith, A. P., Agarwal, A., McCain, M. L. & Parker, K. K. Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. Lab Chip 14, 3925–3936 (2014).
pubmed: 25093641
pmcid: 4167568
doi: 10.1039/C4LC00688G
van der Meer, A. D., Orlova, V. V., ten Dijke, P., van den Berg, A. & Mummery, C. L. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. Lab Chip 13, 3562–3568 (2013).
pubmed: 23702711
doi: 10.1039/c3lc50435b
pmcid: 23702711
Cruz, N. M. et al. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat. Mater. 16, 1112 (2017).
pubmed: 28967916
pmcid: 5936694
doi: 10.1038/nmat4994
Faal, T. et al. Induction of mesoderm and neural crest-derived pericytes from human pluripotent stem cells to study blood-brain barrier interactions. Stem Cell Rep. 12, 451–460 (2019).
doi: 10.1016/j.stemcr.2019.01.005
Rooney, G. E. et al. Human iPS cell-derived neurons uncover the impact of increased ras signaling in Costello syndrome. J. Neurosci. 36, 142 (2016).
pubmed: 26740656
pmcid: 4701956
doi: 10.1523/JNEUROSCI.1547-15.2016
Atchison, L., Zhang, H., Cao, K. & Truskey, G. A. A tissue engineered blood vessel model of Hutchinson-Gilford progeria syndrome using human iPSC-derived smooth muscle cells. Sci. Rep. 7, 8168 (2017).
pubmed: 28811655
pmcid: 5557922
doi: 10.1038/s41598-017-08632-4
Wang, G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616–623 (2014). Rare paediatric disease modelled on an OoC and mechanism of disease uncovered using gene editing techniques.
pubmed: 24813252
pmcid: 4172922
doi: 10.1038/nm.3545
Ben Jehuda, R., Shemer, Y. & Binah, O. Genome editing in induced pluripotent stem cells using CRISPR/Cas9. Stem Cell Rev. Rep. 14, 323–336 (2018).
pubmed: 29623532
doi: 10.1007/s12015-018-9811-3
pmcid: 29623532
Nguyen, D.-H. T. et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc. Natl Acad. Sci. USA 110, 6712–6717 (2013).
pubmed: 23569284
pmcid: 3637738
doi: 10.1073/pnas.1221526110
Montanez-Sauri, S. I., Sung, K. E., Berthier, E. & Beebe, D. J. Enabling screening in 3D microenvironments: probing matrix and stromal effects on the morphology and proliferation of T47D breast carcinoma cells. Integr. Biol. 5, 631–640 (2013).
doi: 10.1039/c3ib20225a
Zervantonakis, I. K. et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc. Natl Acad. Sci. USA 109, 13515 (2012).
pubmed: 22869695
pmcid: 3427099
doi: 10.1073/pnas.1210182109
Jeon, J. S. et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc. Natl Acad. Sci. USA 112, 214–219 (2015).
pubmed: 25524628
doi: 10.1073/pnas.1417115112
pmcid: 25524628
Clark, A. M. et al. A model of dormant-emergent metastatic breast cancer progression enabling exploration of biomarker signatures. Mol. Cell. Proteomics 17, 619 (2018).
pubmed: 29353230
pmcid: 5880110
doi: 10.1074/mcp.RA117.000370
Shirure, V. S. et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip 18, 3687–3702 (2018).
pubmed: 30393802
doi: 10.1039/C8LC00596F
pmcid: 30393802
Regier, M. C. et al. Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments. Biomed. Microdevices 18, 70 (2016).
pubmed: 27432323
pmcid: 5076020
doi: 10.1007/s10544-016-0083-x
Marturano-Kruik, A. et al. Human bone perivascular niche-on-a-chip for studying metastatic colonization. Proc. Natl Acad. Sci. USA 115, 1256 (2018).
pubmed: 29363599
pmcid: 5819403
doi: 10.1073/pnas.1714282115
Kim, S., Lee, H., Chung, M. & Jeon, N. L. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip 13, 1489–1500 (2013).
pubmed: 23440068
doi: 10.1039/c3lc41320a
pmcid: 23440068
Miller, C. P., Tsuchida, C., Zheng, Y., Himmelfarb, J. & Akilesh, S. A 3D human renal cell carcinoma-on-a-chip for the study of tumor angiogenesis. Neoplasia 20, 610–620 (2018).
pubmed: 29747161
pmcid: 5994779
doi: 10.1016/j.neo.2018.02.011
Hassell, B. A. et al. Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro. Cell Rep. 21, 508–516 (2017).
pubmed: 29020635
doi: 10.1016/j.celrep.2017.09.043
pmcid: 29020635
Lee, J.-H. et al. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. J. Exp. Clin. Cancer Res. 37, 4 (2018).
pubmed: 29329547
pmcid: 5767067
doi: 10.1186/s13046-017-0654-6
Jeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S. & Kuh, H.-J. Co-culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment. PLoS ONE 11, e0159013 (2016).
pubmed: 27391808
pmcid: 4938568
doi: 10.1371/journal.pone.0159013
Rizvi, I. et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc. Natl Acad. Sci. USA 110, E1974 (2013).
pubmed: 23645635
pmcid: 3670329
doi: 10.1073/pnas.1216989110
Li, R. et al. Macrophage-secreted TNFα and TGFβ1 influence migration speed and persistence of cancer cells in 3D tissue culture via independent pathways. Cancer Res. 77, 279 (2017).
pubmed: 27872091
doi: 10.1158/0008-5472.CAN-16-0442
pmcid: 27872091
Wang, N. et al. 3D microfluidic in vitro model and bioinformatics integration to study the effects of Spatholobi Caulis tannin in cervical cancer. Sci. Rep. 8, 12285 (2018).
pubmed: 30115981
pmcid: 6095931
doi: 10.1038/s41598-018-29848-y
Low, L. A. & Tagle, D. A. Tissue chips to aid drug development and modeling for rare diseases. Expert Opin. Orphan Drugs 4, 1113–1121 (2016).
pubmed: 28626620
pmcid: 5472383
doi: 10.1080/21678707.2016.1244479
Shik Mun, K. et al. Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders. Nat. Commun. 10, 3124 (2019).
pubmed: 31311920
pmcid: 6635497
doi: 10.1038/s41467-019-11178-w
Shahjalal, H. M., Abdal Dayem, A., Lim, K. M., Jeon, T.-i & Cho, S.-G. Generation of pancreatic β cells for treatment of diabetes: advances and challenges. Stem Cell Res. Ther. 9, 355 (2018).
pubmed: 30594258
pmcid: 6310974
doi: 10.1186/s13287-018-1099-3
Takebe, T., Zhang, B. & Radisic, M. Synergistic engineering: organoids meet organs-on-a-chip. Cell Stem Cell 21, 297–300 (2017).
pubmed: 28886364
doi: 10.1016/j.stem.2017.08.016
pmcid: 28886364
Park, S. E., Georgescu, A. & Huh, D. Organoids-on-a-chip. Science 364, 960 (2019).
pubmed: 31171693
pmcid: 7764943
doi: 10.1126/science.aaw7894
Takebe, T. et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 16, 556–565 (2015).
pubmed: 25891906
doi: 10.1016/j.stem.2015.03.004
pmcid: 25891906
Zhang, Y. S. et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 110, 45–59 (2016).
pubmed: 27710832
pmcid: 5198581
doi: 10.1016/j.biomaterials.2016.09.003
Park, D., Lee, J., Chung, J. J., Jung, Y. & Kim, S. H. Integrating organs-on-chips: multiplexing, scaling, vascularization, and innervation. Trends Biotechnol. https://doi.org/10.1016/j.tibtech.2019.06.006 (2019).
doi: 10.1016/j.tibtech.2019.06.006
pubmed: 31345572
pmcid: 31345572
Edington, C. D. et al. Interconnected microphysiological systems for quantitative biology and pharmacology studies. Sci. Rep. 8, 4530 (2018). Multi-organ microfluidic ‘physiome-on-a-chip’ platform modelling up to 10 organs for 4 weeks with pharmacokinetic analysis of diclofenac metabolism, noting general design and operational principles for multi-organ platforms.
pubmed: 29540740
pmcid: 5852083
doi: 10.1038/s41598-018-22749-0
Novak, R. et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat. Biomed. Eng. 4, 407–420 (2020). Multi-organ linked system for up to 10 OoCs for 3 weeks in automated culture and perfusion machine capable of medium addition, fluidic linking, sample collection and in situ microscopy.
pubmed: 31988458
pmcid: 8057865
doi: 10.1038/s41551-019-0497-x
Shim, M. K. et al. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy. J. Control. Release 294, 376–389 (2019).
pubmed: 30550940
doi: 10.1016/j.jconrel.2018.11.032
pmcid: 30550940
Al-Malahmeh, A. J. et al. Physiologically based kinetic modeling of the bioactivation of myristicin. Arch. Toxicol. 91, 713–734 (2017).
pubmed: 27334372
doi: 10.1007/s00204-016-1752-5
pmcid: 27334372
Schurdak, M. E. et al. in Phenotypic Screening: Methods and Protocols (ed. Wagner B.) 207–222 (Springer, 2018).
Oliver, C. R. et al. A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche. Lab Chip https://doi.org/10.1039/C8LC01387J (2019).
doi: 10.1039/C8LC01387J
pubmed: 30810557
pmcid: 6510031
Satoh, T. et al. A multi-throughput multi-organ-on-a-chip system on a plate formatted pneumatic pressure-driven medium circulation platform. Lab Chip 18, 115–125 (2018).
doi: 10.1039/C7LC00952F
Boos, J. A., Misun, P. M., Michlmayr, A., Hierlemann, A. & Frey, O. Microfluidic multitissue platform for advanced embryotoxicity testing in vitro. Adv. Sci. 6, 1900294–1900294 (2019).
doi: 10.1002/advs.201900294
Vunjak-Novakovic, G., Bhatia, S., Chen, C. & Hirschi, K. HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease. Stem Cell Res. Ther. 4, 1–6 (2013).
doi: 10.1186/scrt383
Vernetti, L. et al. Functional coupling of human microphysiology systems: intestine, liver, kidney proximal tubule, blood-brain barrier and skeletal muscle. Sci. Rep. 7, 42296 (2017).
pubmed: 28176881
pmcid: 5296733
doi: 10.1038/srep42296
Brown, J. A. et al. Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor. Biomicrofluidics 9, 054124 (2015).
pubmed: 26576206
pmcid: 4627929
doi: 10.1063/1.4934713
Brown, J. A. et al. Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit. J. Neuroinflammation 13, 306 (2016).
pubmed: 27955696
pmcid: 5153753
doi: 10.1186/s12974-016-0760-y
Maoz, B. M. et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells. Nat. Biotechnol. 36, 865 (2018).
pubmed: 30125269
doi: 10.1038/nbt.4226
pmcid: 30125269
Chen, W. L. K. et al. Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk. Biotechnol. Bioeng. 114, 2648–2659 (2017).
pubmed: 28667746
pmcid: 5614865
doi: 10.1002/bit.26370
Esch, M. B., Ueno, H., Applegate, D. R. & Shuler, M. L. Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue. Lab Chip 16, 2719–2729 (2016).
pubmed: 27332143
doi: 10.1039/C6LC00461J
pmcid: 27332143
Loskill, P., Marcus, S. G., Mathur, A., Reese, W. M. & Healy, K. E. μOrgano: a Lego®-like plug & play system for modular multi-organ-chips. PLoS ONE 10, e0139587 (2015).
pubmed: 26440672
pmcid: 4595286
doi: 10.1371/journal.pone.0139587
Xiao, S. et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat. Commun. 8, 14584 (2017). Human female reproductive system and cycle recreated on a five-organ platform with inclusion of endocrine signalling to mimic hormonal markers of pregnancy as a tool for female reproductive toxicity assessment.
pubmed: 28350383
pmcid: 5379057
doi: 10.1038/ncomms14584
Skardal, A., Shupe, T. & Atala, A. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. Drug Discov. Today 21, 1399–1411 (2016).
pubmed: 27422270
doi: 10.1016/j.drudis.2016.07.003
pmcid: 27422270
Skardal, A. et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci. Rep. 7, 8837 (2017).
pubmed: 28821762
pmcid: 5562747
doi: 10.1038/s41598-017-08879-x
Oleaga, C. et al. Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system. Biomaterials 182, 176–190 (2018).
pubmed: 30130706
pmcid: 6126670
doi: 10.1016/j.biomaterials.2018.07.062
Sakolish, C. et al. Technology transfer of the microphysiological systems: a case study of the human proximal tubule tissue chip. Sci. Rep. 8, 14882–14882 (2018).
pubmed: 30291268
pmcid: 6173737
doi: 10.1038/s41598-018-33099-2
Roberts, R. A. et al. Reducing attrition in drug development: smart loading preclinical safety assessment. Drug Discov. Today 19, 341–347 (2014).
pubmed: 24269835
doi: 10.1016/j.drudis.2013.11.014
pmcid: 24269835
Livingston, C. A., Fabre, K. M. & Tagle, D. A. Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public–private partnerships. Comput. Struct. Biotechnol. J. 14, 207–210 (2016).
pubmed: 27904714
pmcid: 5122750
doi: 10.1016/j.csbj.2016.04.003
Schurdak, M. et al. Applications of the microphysiology systems database for experimental ADME-Tox and disease models. Lab Chip 20, 1472–1492 (2020).
pubmed: 32211684
pmcid: 7497411
doi: 10.1039/C9LC01047E
Lee, J. et al. Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacol. Ther. https://doi.org/10.1016/j.pharmthera.2020.107501 (2020).
doi: 10.1016/j.pharmthera.2020.107501
pubmed: 33359599
pmcid: 33359599
Franzen, N. et al. Impact of organ-on-a-chip technology on pharmaceutical R&D costs. Drug Discov. Today 24, 1720–1724 (2019).
pubmed: 31185290
doi: 10.1016/j.drudis.2019.06.003
pmcid: 31185290
Sances, S. et al. Human iPSC-derived endothelial cells and microengineered organ-chip enhance neuronal development. Stem Cell Rep. 10, 1222–1236 (2018). Increased calcium transients and mature gene expression seen in spinal motor neurons and brain microvascular endothelial cells derived from iPS cells when cultured on a 3D OoC versus a 96-well plate.
doi: 10.1016/j.stemcr.2018.02.012
Mulholland, T. et al. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient. Sci. Rep. 8, 14672 (2018).
pubmed: 30279484
pmcid: 6168499
doi: 10.1038/s41598-018-33055-0
Schutgens, F. et al. Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat. Biotechnol. 37, 303–313 (2019).
pubmed: 30833775
doi: 10.1038/s41587-019-0048-8
Ronaldson-Bouchard, K. & Vunjak-Novakovic, G. Organs-on-a-chip: a fast track for engineered human tissues in drug development. Cell Stem Cell 22, 310–324 (2018).
pubmed: 29499151
pmcid: 5837068
doi: 10.1016/j.stem.2018.02.011
McAleer, C. W. et al. Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics. Sci. Transl. Med. 11, eaav1386 (2019).
pubmed: 31217335
doi: 10.1126/scitranslmed.aav1386
Wagner, J. A. et al. Application of a dynamic map for learning, communicating, navigating, and improving therapeutic development. Clin. Transl. Sci. 11, 166–174 (2017).
pubmed: 29271559
pmcid: 5866991
doi: 10.1111/cts.12531
Wagner, J. A. et al. Drug Discovery, Development and Deployment Map (4DM): Small Molecules. National Center for Advancing Translational Sciences https://ncats.nih.gov/translation/maps (NIH).
Peterson, N. C., Mahalingaiah, P. K., Fullerton, A. & Di Piazza, M. Application of microphysiological systems in biopharmaceutical research and development. Lab Chip 20, 697–708 (2020).
pubmed: 31967156
doi: 10.1039/C9LC00962K
pmcid: 31967156
Hardwick, R. N. et al. Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays. Lab Chip 20, 199–214 (2020).
pubmed: 31598618
doi: 10.1039/C9LC00519F
pmcid: 31598618
Ainslie, G. R. et al. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective. Lab Chip 19, 3152–3161 (2019).
pubmed: 31469131
doi: 10.1039/C9LC00492K
Peters, M. F. et al. Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems. Lab Chip 20, 1177–1190 (2020).
pubmed: 32129356
doi: 10.1039/C9LC01107B
pmcid: 32129356
Phillips, J. A. et al. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies. Lab Chip 20, 468–476 (2020).
pubmed: 31989145
doi: 10.1039/C9LC00925F
pmcid: 31989145
Baudy, A. R. et al. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 20, 215–225 (2020).
pubmed: 31799979
doi: 10.1039/C9LC00768G
pmcid: 31799979
Yeung, C. K. et al. Tissue chips in space — challenges and opportunities. Clin. Transl. Sci. https://doi.org/10.1111/cts.12689 (2019).
doi: 10.1111/cts.12689
pubmed: 31524321
pmcid: 6951467
Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010).
pubmed: 20644535
pmcid: 3150836
doi: 10.1038/nature09342